Triptan Nonresponder Studies: Implications for Clinical Practice
- 10 February 2005
- journal article
- research article
- Published by Wiley in Headache: The Journal of Head and Face Pain
- Vol. 45 (2), 156-162
- https://doi.org/10.1111/j.1526-4610.2005.05031.x
Abstract
The maximum absolute response rate with oral triptans, as measured in clinical trials by the incidence of relief from migraine pain at 2 hours after taking medication, is approximately 70%. Therefore around 30% of patients fail to respond to a particular triptan. Nonresponse is likely to be due to a variety of factors, including low and inconsistent absorption, use of the medication late in an attack, inadequate dosing, and variability in individual response. Evidence from recent clinical trials, however, confirms the common clinical observation that patients with a poor response to one triptan can benefit from subsequent treatment with a different triptan. Two-hour pain-relief rates of 25% to 81% using alternative triptans (naratriptan, almotriptan, eletriptan, zolmitriptan, and rizatriptan) have been reported in patients who were described as poor responders to sumatriptan. Physicians should remain vigilant in assessing the response to acute therapy and take advantage of simple clinical questionnaires that have been developed to facilitate the recognition of those patients who require and may benefit from a change in acute therapy.Keywords
This publication has 24 references indexed in Scilit:
- Identifying patients who require a change in their current acute migraine treatment: the Migraine Assessment of Current Therapy (Migraine-ACT) questionnaireCurrent Medical Research and Opinion, 2004
- Almotriptan Improves Response Rates When Treatment Is Within 1 Hour of Migraine OnsetHeadache: The Journal of Head and Face Pain, 2004
- Defeating migraine pain with triptans: A race against the development of cutaneous allodyniaAnnals of Neurology, 2003
- The Triptan FormulationsCNS Drugs, 2003
- Diagnosis and Treatment of MigraineMayo Clinic Proceedings, 2002
- Is There a Preferred Triptan?Headache: The Journal of Head and Face Pain, 2002
- Advances in pharmacological treatment of migraineExpert Opinion on Investigational Drugs, 2001
- Triptans in MigraineDrugs, 2000
- Acute Migraine Therapy: Do Doctors Understand What Patients With Migraine Want From Therapy?Headache: The Journal of Head and Face Pain, 1999
- SumatriptanDrugs, 1998